Literature DB >> 20960196

[Multiple endocrine neoplasia type 2].

S-Y Sheu1, K W Schmid.   

Abstract

Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant inherited cancer syndrome with the major components medullary thyroid carcinoma, pheochromocytoma and hyperparathyroidism. Due to the clinical course three distinct subtypes are distinguished, MEN 2A, MEN 2B and familial medullary thyroid carcinoma. The disease is caused by germ-line mutations of the RET proto-oncogene and the localization of these mutations correlates with the onset of the development of medullary thyroid carcinoma, which is crucial for the clinical course and outcome of the disease. It therefore has a substantial influence on the clinical management of the affected patients and their relatives. This review summarizes the morphology and clinic of MEN 2-associated tumors and their respective precursor lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960196     DOI: 10.1007/s00292-010-1389-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  10 in total

1.  Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia.

Authors:  Enrico Saggiorato; Ida Rapa; Francesca Garino; Gianni Bussolati; Fabio Orlandi; Mauro Papotti; Marco Volante
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.

Authors:  K Kaserer; C Scheuba; N Neuhold; A Weinhäusel; O A Haas; H Vierhapper; B Niederle
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

Review 4.  Multiple endocrine neoplasia type 2.

Authors:  Nelson Wohllk; Heiko Schweizer; Zoran Erlic; Kurt Werner Schmid; Martin K Walz; Friedhelm Raue; Hartmut P H Neumann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

5.  Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.

Authors:  Michael Brauckhoff; Andreas Machens; Sören Hess; Kerstin Lorenz; Oliver Gimm; Katrin Brauckhoff; Carsten Sekulla; Henning Dralle
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

6.  Evidence of MEN-2 in the original description of classic pheochromocytoma.

Authors:  Hartmut P H Neumann; Alexander Vortmeyer; Dieter Schmidt; Martin Werner; Zoran Erlic; Alberto Cascon; Birke Bausch; Andrzej Januszewicz; Charis Eng
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

7.  Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

Authors:  Rossella Elisei; Barbara Cosci; Cristina Romei; Valeria Bottici; Giulia Renzini; Eleonora Molinaro; Laura Agate; Agnese Vivaldi; Pinuccia Faviana; Fulvio Basolo; Paolo Miccoli; Piero Berti; Furio Pacini; Aldo Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

Review 8.  [Thyroid tumors].

Authors:  K W Schmid; S-Y Sheu; R Görges; C Ensinger; M Tötsch
Journal:  Pathologe       Date:  2003-09       Impact factor: 1.011

Review 9.  Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.

Authors:  Friedhelm Raue; Karin Frank-Raue
Journal:  Hormones (Athens)       Date:  2009 Jan-Mar       Impact factor: 2.885

10.  "Atypical" medullary thyroid carcinoma with little or no calcitonin expression.

Authors:  K W Schmid; C Ensinger
Journal:  Virchows Arch       Date:  1998-09       Impact factor: 4.064

  10 in total
  6 in total

Review 1.  [Clinical importance of thyroid gland cytology].

Authors:  S Ting; S Synoracki; A Bockisch; D Führer; K W Schmid
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

2.  [Intraoperative frozen sections of the thyroid gland].

Authors:  S Synoracki; S Ting; U Siebolts; H Dralle; O Koperek; K W Schmid
Journal:  Pathologe       Date:  2015-07       Impact factor: 1.011

Review 3.  [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].

Authors:  S Ting; S Synoracki; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

4.  [Familial thyroid carcinomas].

Authors:  K W Schmid; S Ting; S-Y Sheu
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 5.  [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Authors:  S Synoracki; S T Schmid; S Ting; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

6.  [Medullary thyroid carcinoma].

Authors:  V Tiedje; S Ting; H Dralle; K W Schmid; D Führer
Journal:  Internist (Berl)       Date:  2015-09       Impact factor: 0.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.